Navigation Links
Tax Specialty Firm McGuire Sponsel Urges Qualifying Biotech Companies to Apply for New Qualifying Therapeutic Discovery Project Credit Soon
Date:6/1/2010

INDIANAPOLIS, June 1 /PRNewswire/ -- Small- to mid-sized biotech companies can soon apply for a new tax incentive that allows them to claim a credit for 50 percent of their qualified investment in new medical technologies for tax years 2009 and 2010.

The Qualifying Therapeutic Discovery Project Credit is part of the Patient Protection and Affordable Care Act created by the Obama administration and signed into law in March. The bill states that qualified therapeutic discovery projects must involve activities that are designed to treat areas of unmet medical need. New technologies can also be designed to prevent, detect, treat and potentially cure chronic or acute diseases and conditions.

"The incentive will provide the capital these biotech companies need to further their research and development programs in hopes of creating new treatments, therapies and cures for disease," said TJ Sponsel, director at specialty tax firm McGuire Sponsel. "It is a great opportunity for qualifying companies but they have to act fast. Once the money is gone, it's gone."

Companies applying for the credit must submit applications from June 21 through July 21. The Internal Revenue Service will issue certifications by Oct. 29. Taxpayers must file a separate application for each qualified investment being pursued and qualified investments are capped at $10 million per taxpayer.

"Qualified investments include wages, supplies and lab costs, depreciable property, contractor costs and other development costs," Sponsel said. "There will be an emphasis placed on qualitative aspects of the research and experimentation focused on creating high-quality, high-paying jobs in the U.S. and advancing the country's overall competitiveness in the fields of life, biological and medical sciences."

All claims must be substantiated with supporting narratives, including a discussion of scientific rationale and evidence relied on for the project, a description of the nature of development of the project and a description of the resources, management experience and organizational capacity of the applicant. Congress has asked the treasury department to approve qualified applications within 30 days.

To learn more in-depth details and guidelines for applying for a Qualifying Therapeutic Discovery Project Credit, visit www.mcguiresponsel.com/biotech or call Sponsel at (317) 564-5002.


'/>"/>
SOURCE McGuire Sponsel
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Patient Treatment for Bipolar Disorder Varies Depending on Doctor Specialty; Well Designed Clinical Trials May Be The Answer
2. Baxter Adds Recombinant Protein to Specialty Therapeutics Portfolio
3. Diplomat Specialty Pharmacy Health Services Division Achieves High Marks in Pilot Program for Chronic Kidney Disease Management
4. Diplomat Specialty Pharmacy Hires Vice President of Managed Markets
5. Diplomat Specialty Pharmacy Hires National Accounts Manager to Expand Multiple Sclerosis Program
6. Botaneco signs feasibility agreement with Croda to develop specialty crop oil formulation
7. West Pharmaceutical Services to Present at the 2008 UBS Global Specialty & Generic Pharmaceuticals Conference
8. Atrium completes the sale of its Active Ingredients and Specialty Chemicals division
9. 60 Specialty Chemical, Fine Chemical & Custom Synthesis Providers Will Exhibit at Pharma ChemOutsourcing on September 8-9 in New Jersey
10. Diplomat Specialty Pharmacy Sponsors National Managed Care Roundtable for Industry Executive Advisory Board
11. A Perfect Storm Threatens Patient Access to Specialty Medical Care
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/11/2017)... , ... January 11, 2017 , ... ... are observed in clinical settings, it is becoming increasingly clear that the evolution ... on culture-based methods, the standard in the study of clinical resistance, has vastly ...
(Date:1/11/2017)... ... January 11, 2017 , ... IsoPlexis Corporation ... platform to measure the proteomic function of individual cells in patients, today announced ... grant from the National Institute on Aging of the National Institutes of Health ...
(Date:1/11/2017)... Collins, Colorado (PRWEB) , ... January 11, 2017 ... ... of dynamic aqueous plasma technology platforms, announced today that the National Science Foundation ... IIB supplement for $500,000. The funds will be used to commercialize the Symbios ...
(Date:1/11/2017)... ... January 11, 2017 , ... Advanced Polymer Monitoring Technologies (APMT) ... Bartylla will lead European initiatives for APMT’s product lines serving polymer and biopharmaceutical ... to European manufacturers and researchers. Bernhard brings significant experience in our application areas ...
Breaking Biology Technology:
(Date:12/15/2016)... ... and Markets has announced the addition of the "Global Military Biometrics ... forecasts the global military biometrics market to grow at a CAGR of ... prepared based on an in-depth market analysis with inputs from industry experts. ... coming years. The report also includes a discussion of the key vendors ...
(Date:12/8/2016)... India , Dec. 8, 2016 Market Research Future ... Service Market. The global Mobile Biometric Security and Service Market is ... 2016 to 2022. Market Highlights: ... , , Mobile ... pace due to the increasing need of authentication and security from ...
(Date:12/7/2016)... , Dec. 7, 2016   Veridium , ... the appointment of new CEO James Stickland ... with decades of experience, has served in senior ... where he specialized in expanding a pipeline of ... portfolios. He most recently served as managing director ...
Breaking Biology News(10 mins):